跳至主要内容
临床试验/NCT00683202
NCT00683202已完成不适用

The Significance of Low-Dose Aspirin on Ovarian Responsiveness, Uterine Hemodynamics and Pregnancy Outcome in in Vitro Fertilization and in Intracytoplasmic Sperm Injection: A Randomized, Placebo-Controlled Double-Blind Study

University of Oulu1 个研究点 分布在 1 个国家目标入组 374 人开始时间: 2001年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
374
试验地点
1
主要终点
Pregnancy rate

研究概览

简要总结

In this study we hypothesized that low-dose aspirin therapy (100 mg daily) improves ovarian responsiveness, uterine haemodynamics and clinical pregnancy rates in unselected subjects undergoing IVF/ICSI when the treatment is started concomitantly with controlled ovarian hyperstimulation.

详细描述

Low-dose acetylsalicylic acid irreversibly inhibits the cyclo-oxygenase enzyme in platelets, thus preventing the synthesis of thromboxane, which causes vasoconstriction and platelet aggregation. By this mechanism low-dose aspirin may enhance ovarian and uterine blood flow and tissue perfusion and thus improve ovarian responsiveness for gonadotrophins and endometrial receptivity for implantation. Randomized controlled studies and meta-analyses on the low-dose aspirin therapy to improve IVF/ICSI outcome or uterine hemodynamics have revealed conflicting results.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 39 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • age < 40 years
  • < 4 previous ovarian stimulations

排除标准

  • allergy for acetylsalicylic acid

研究组 & 干预措施

1

Active Comparator

Acetylsalicylic acid 100 mg daily perorally

干预措施: Acetylsalicylic acid (Drug)

2

Placebo Comparator

Placebo daily perorally

干预措施: Placebo (Drug)

结局指标

主要结局

Pregnancy rate

时间窗: Five weeks after embryo transfer

次要结局

  • Uterine artery and spiral artery pulsatility index values(On the day of embryo transfer)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验